When the Washington Post headlined a story on February 27 that White House thinking on health care reform is "in flux," it noted that President Trump was somewhat uninvolved in many of the emerging issues except for a few near to his heart, such as controlling drug price increases. President Trump has taken up the issue of drug prices in a way President Obama never did. In Trump's January meeting with chief executive officers of drug companies, he said drug companies are "getting away with murder." He indicated that he would support allowing Medicare to negotiate pricing with drug companies, an issue he waffled on during his campaign. That is anathema to drug manufacturers. "We're the largest buyer of drugs in the world, and yet we don't bid properly, and we're going to start bidding, and we're going to save billions of dollars over a period of time," the President said.
展开▼
